Jubilant Pharmova Limited (BOM:530019)
India · Delayed Price · Currency is INR 985.25
-21.85 (-2.17%)
At close: May 26, 2026
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 156.06 billion as of May 27, 2026. Its market cap has increased by 11.72% in one year.
Market Cap
156.06B
Enterprise Value
179.56B
Revenue
82.80B
Ranking
n/a
PE Ratio
39.28
Stock Price
985.25
Market Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 156.06B, an increase of 38,269.44%. That is a compound annual growth rate of 25.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 156.06B | -8.33% |
| Dec 31, 2025 | 170.24B | -2.67% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 386.78B |
| J. B. Chemicals & Pharmaceuticals | 351.43B |
| AstraZeneca Pharma India | 224.60B |
| Granules India | 187.53B |
| Rubicon Research | 161.08B |
| Caplin Point Laboratories | 154.72B |
| Viyash Scientific | 112.11B |
| CORONA Remedies | 103.79B |